Company Overview of Celecure AS
Celecure AS engages in the drug discovery and development of anticancer drugs. Its pipeline products include SB101, an angiogenesis inhibitor; CC0101, a tumor cell specific growth inhibitor; and Entrybodies, which are antibodies blocking intracellular proteins. The company was founded in 2002 and is based in Tallinn, Estonia.
Akadeemia tee 15
Founded in 2002
372 6 204 350
Key Executives for Celecure AS
Similar Private Companies By Industry
|Tallinna Farmaatsiatehase AS||Europe|
|Merck Sharp & Dohme O.U.||Europe|
|GlaxoSmithKline Eesti OU||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Celecure AS, please visit www.celecure.com. Company data is provided by Capital IQ. Please use this form to report any data issues.